Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Maria Eugenia
Maria Eugenia Balana, Buenos Aires AR
| Patent application number | Description | Published |
|---|---|---|
| 20100183703 | PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING A DOUBLE STRANDED RNA OLIGONUCLEOTIDE AND ITS USE AS AN ACTIVE PHARMACEUTICAL INGREDIENT IN THE TREATMENT OF ANDROGEN RELATED DISEASES - This invention refers to new double stranded oligonucleotides having specific antiandrogenic activity and particularly to their use in the treatment of androgen-related diseases. Oligonucleotides may preferably be formulated with an acceptable pharmaceutical support in pharmaceutical or cosmetic formulations which are related to androgen metabolism or aimed at providing a beneficial effect on skin and/or hair. | 07-22-2010 |
| 20100311813 | ANTIANDROGEN OLIGONUCLEOTIDES USABLE FOR THE TREATMENT OF DERMATOLOGICAL ANDROGEN-RELATED DISORDERS RELATING TO ANDROGEN METABOLISM, THEIR PHARMACEUTICAL COMPOSITIONS, THEIR USES AND TREATMENT METHOD - Antiandrogen oligonucleotides suitable for the treatment of hair loss and androgen-metabolism related skin disorders. The oligonucleotides having the sequences: | 12-09-2010 |
Maria Eugenia Carlotti, Torino IT
| Patent application number | Description | Published |
|---|---|---|
| 20110293537 | FORMULATIONS WITH ANTI-NEOPLASTIC ACTIVITY - Pharmaceutical formulation comprising at least one aryl hydrocarbon receptor ligand and at least one cyclodextrin for the prevention and/or treatment of carcinomas, preferably squamous cell carcinomas, more preferably oral squamous cell carcinomas. | 12-01-2011 |
Maria Eugenia Nunez Calzado, Valencia ES
| Patent application number | Description | Published |
|---|---|---|
| 20110142899 | ACTIVE NANOCOMPOSITE MATERIALS AND PRODUCTION METHOD THEREOF - SUMMARY The present invention refers to new active nanocomposite materials, comprising a matrix and additives. The present invention also describes a process for obtaining these nanocomposite materials and their use in various industry sectors. | 06-16-2011 |
Maria Eugenia Sáez, Sevilla ES
| Patent application number | Description | Published |
|---|---|---|
| 20090208928 | Method and device for the in vitro detection of polycystic ovarian syndrome (pcos) and pathologies involving cardiovascular risk - The invention relates to a method and device for the in vitro detection of polycystic ovary syndrome (PCOS) and pathologies involving cardiovascular risk. An in vitro assay method and assay device (kit) for the diagnosis of the presence or the predisposition to suffer from PCOS and/or cardiovascular risk factors including: general obesity, abdominal obesity, hypertension, glucose intolerance, diabetes, hyperinsulinemia, general hypercholesterolemia, hypercholesterolemia with high LDL-cholesterol levels, low HDL-cholesterol levels and hypertriglyceridemia, as well as the grouping of some of these cardiovascular risk factors known as metabolic syndrome. The method and the kit are characterized in that they are based on the detection of at least one genotype or haplotype of a polymorphism in the CAPN5 gene selected from: Nt g.86 A>G, Nt g.344 G>A, Nt c.1320 C>T and Nt c.1469 G>A or combinations thereof. | 08-20-2009 |
| 20100203502 | Method for the in Vitro Detection of a Predisposition to the Development of Alterations in Ovarian Function - The invention relates to a method for the in vitro detection of a predisposition to the development of alterations in ovarian function. The inventive method is based on the detection of polymorphisms −673C>T, −9C>G, IVS1+905A>G and N103S of gene BMP15 and combinations of same. The invention can be used for the diagnosis or prognosis of a predisposition in women to alterations in ovarian function, such as the onset of menopause at an unusually young age, including both early menopause and premature ovarian failure, a reduction in the reproductive window or the development of ovarian hyperstimulation syndrome (OHS) following controlled ovarian stimulation (COS) with FSH in treatments to increase fertility. | 08-12-2010 |
Maria Eugenia Sáez, Sevilla ES
| Patent application number | Description | Published |
|---|---|---|
| 20100203502 | Method for the in Vitro Detection of a Predisposition to the Development of Alterations in Ovarian Function - The invention relates to a method for the in vitro detection of a predisposition to the development of alterations in ovarian function. The inventive method is based on the detection of polymorphisms −673C>T, −9C>G, IVS1+905A>G and N103S of gene BMP15 and combinations of same. The invention can be used for the diagnosis or prognosis of a predisposition in women to alterations in ovarian function, such as the onset of menopause at an unusually young age, including both early menopause and premature ovarian failure, a reduction in the reproductive window or the development of ovarian hyperstimulation syndrome (OHS) following controlled ovarian stimulation (COS) with FSH in treatments to increase fertility. | 08-12-2010 |